TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.71B
1-Year Return 19.93%
This Quarter Return
-0.84%
1 Year Return
+19.93%
3 Year Return
+90.1%
5 Year Return
+158.53%
10 Year Return
+284.02%
AUM
$1.13B
AUM Growth
+$319M
Cap. Flow
+$366M
Cap. Flow %
32.44%
Top 10 Hldgs %
55.39%
Holding
5,890
New
1,133
Increased
1,666
Reduced
1,680
Closed
1,188

Sector Composition

1 Financials 2.49%
2 Industrials 2.22%
3 Healthcare 2.07%
4 Consumer Discretionary 2.05%
5 Energy 1.8%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SQNS
5126
Sequans Communications
SQNS
$139M
-10
Closed
SRDX icon
5127
Surmodics
SRDX
$458M
-1,628
Closed -$42K
SSD icon
5128
Simpson Manufacturing
SSD
$8.08B
-4,017
Closed -$151K
SSG icon
5129
ProShares UltraShort Semiconductors
SSG
$6.69M
0
-$14K
SSL icon
5130
Sasol
SSL
$4.55B
-6,377
Closed -$217K
SSO icon
5131
ProShares Ultra S&P500
SSO
$7.4B
-13,888
Closed -$224K
SSY
5132
DELISTED
SunLink Health Systems
SSY
$0 ﹤0.01%
18
-10
-36%
STEW
5133
SRH Total Return Fund
STEW
$1.78B
0
STLD icon
5134
Steel Dynamics
STLD
$19.9B
-3,117
Closed -$63K
SWK icon
5135
Stanley Black & Decker
SWK
$12.3B
-1,204
Closed -$115K
SWKS icon
5136
Skyworks Solutions
SWKS
$10.9B
-985
Closed -$97K
SWX icon
5137
Southwest Gas
SWX
$5.7B
-581
Closed -$34K
SWZ
5138
Swiss Helvetia Fund
SWZ
$79.5M
-63
Closed -$1K
SYF icon
5139
Synchrony
SYF
$28.2B
-947
Closed -$29K
T icon
5140
AT&T
T
$210B
-3,879
Closed -$96K
TAIT icon
5141
Taitron Components
TAIT
$17.3M
$0 ﹤0.01%
212
-385
-64%
TAP icon
5142
Molson Coors Class B
TAP
$9.74B
-475
Closed -$35K
TBPH icon
5143
Theravance Biopharma
TBPH
$684M
-10
Closed
TBX icon
5144
ProShares Short 7-10 Year Treasury
TBX
$13.2M
$0 ﹤0.01%
+10
New
TCPC icon
5145
BlackRock TCP Capital
TCPC
$608M
-261
Closed -$4K
TDG icon
5146
TransDigm Group
TDG
$72.8B
-182
Closed -$40K
TDS icon
5147
Telephone and Data Systems
TDS
$4.5B
-13
Closed
TEI
5148
Templeton Emerging Markets Income Fund
TEI
$295M
0
TEL icon
5149
TE Connectivity
TEL
$62.9B
-12
Closed -$1K
TEVA icon
5150
Teva Pharmaceuticals
TEVA
$22.7B
0